1.
Leuk Res
; 117: 106856, 2022 06.
Article
in English
| MEDLINE
| ID: mdl-35525186
ABSTRACT
Around one third of patients with myelodysplastic syndromes (MDS) suffer from concomitant autoimmune disorders (AD). However the actual burden of such an association appears to be quite heterogeneous in different studies probably due to variable criteria in selecting both MDS patients and subtypes of AD. Moreover, both the prognostic implications and the potential applications of specific therapeutic approaches in this patient subgroup are still at least partially under debate. The present review will try to shed some further light on the clinical association between MDS and AD in order to better delineate its prognostic significance and to suggest potential therapeutic algorithms available for these patients.
Subject(s)
Autoimmune Diseases , Myelodysplastic Syndromes , Autoimmune Diseases/complications , Autoimmune Diseases/therapy , Humans , Myelodysplastic Syndromes/complications , Myelodysplastic Syndromes/diagnosis , Myelodysplastic Syndromes/therapy , Prognosis
2.
Ann Hematol
; 101(1): 227-228, 2022 Jan.
Article
in English
| MEDLINE
| ID: mdl-33469687
Subject(s)
Anemia, Hemolytic, Autoimmune/drug therapy , Cytomegalovirus Infections/virology , Cytomegalovirus/drug effects , Immunosuppressive Agents/therapeutic use , Virus Activation/drug effects , Aged , Anemia, Hemolytic, Autoimmune/virology , Cytomegalovirus/physiology , Cytomegalovirus Infections/chemically induced , Female , Humans , Immunosuppressive Agents/adverse effects , Male , Middle Aged
3.
J Pediatr Hematol Oncol
; 43(3): 118-119, 2021 04 01.
Article
in English
| MEDLINE
| ID: mdl-32815882